Navigation Links
Mylan Announces Tentative FDA Approval for Topiramate Capsules
Date:9/10/2007

PITTSBURGH, Sept. 10 /PRNewswire-FirstCall/ -- Mylan Laboratories Inc. (NYSE: MYL) today announced that Mylan Pharmaceuticals Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Topiramate Capsules, 15 mg and 25 mg.

Topiramate Capsules are the generic version of Ortho McNeil Pharmaceuticals' Topamax(R) Sprinkle Capsules which had U.S. sales of approximately $46 million for the 12 months ending June 30, 2007.

Mylan Laboratories Inc. is a leading pharmaceutical company with three principal subsidiaries, Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL Laboratories Inc., and a controlling interest in Matrix Laboratories Limited, India. Mylan develops, licenses, manufactures, markets and distributes an extensive line of generic and proprietary products.

For more information about Mylan, please visit http://www.mylan.com.


'/>"/>
SOURCE Mylan Laboratories Inc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Mylan Wins Its Amlodipine Case With Pfizer
2. Mylan Announces Tentative FDA Approval for Its ANDA
3. Mylan Announces Final FDA Approval for Fluoxetine Capsules
4. PM announces a new health care order for India
5. PowderMed Announces Needle-Less Flu Vaccine
6. Ramdoss Announces Introduction of RCH-II
7. Britain Announces Third Transfusion Related Mad Cow Case
8. Tibet Announces the Dalai Lama’s Tour of South Americ
9. NHS announces further Cost cutting Measures
10. Indian PM Announces Of Setting Up India Study Center At Tashkent
11. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... ... August 15, 2017 , ... ... at his Inauguration that WesternU will move forward in bold new directions while ... WesternU combined Wilson’s Inauguration ceremony with Convocation, the traditional opening of the academic ...
(Date:8/15/2017)... ... August 15, 2017 , ... Horizon Goodwill is honored to ... are overwhelmed with gratitude for the very generous donation from BB&T. Our mission ... both get a job and keep it. This donation will go a long ...
(Date:8/15/2017)... ... August 15, 2017 , ... IsoComforter, Inc., one of the ... innovative new 10x10 bladder pad ( isocomforter.com/product/10x10-sterile-pad/ ). The newly designed bladder pad ... enables the patient to enjoy the benefits of cold therapy while resting, sitting, ...
(Date:8/15/2017)... ... August 15, 2017 , ... Harris Communications, Inc. is bringing its ... Twin Cities Living Well with Hearing Loss Conference, 9:30-2 p.m. Saturday, Nov. 18 at ... for Harris Communications at tables 8 and 9. , During the conference, attendees can ...
(Date:8/15/2017)... Glan Allen,VA (PRWEB) , ... August 15, 2017 ... ... of CoolSculpting to their leading selection of services. FDA-cleared CoolSculpting is the world’s ... and counting. Without surgery or downtime, CoolSculpting can reduce fat cells in almost ...
Breaking Medicine News(10 mins):
(Date:7/27/2017)... Services, Inc. (NYSE: WST ) today announced ... financial guidance for the full-year 2017. ... Reported net sales of $397.6 million, a record high, ... constant currency (organic) grew by 3.9%. ... in the prior-year quarter. Second-quarter 2017 adjusted diluted EPS ...
(Date:7/26/2017)... July 26, 2017 Sancilio Pharmaceuticals Company, Inc. ... clinical trial evaluating Altemia TM , an oral therapy ... Sickle Cell Disease (SCD). The SCOT Trial, is a ... and safety of Altemia TM in pediatric patients ... US IND 125274. ...
(Date:7/25/2017)... -- Debbie,s Dream Foundation: Curing Stomach Cancer (DDF) is excited to host its 3 ... Bonaventure Resort & Spa in Weston, Florida beginning at ... Luncheon Committee Co-chair ... Luncheon Committee Co-chair Sabrina Kurzman. ... Aura Morales-Guzman, Angela Perez, DDF Board Member John ...
Breaking Medicine Technology: